Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines

Infection and Immunity

Volumn 70, Issue 11, 2002, Pages 6383-6388

  Raghavan, S ^a   Hjulstrom M ^a   Holmgren, J ^a   Svennerholm, Ann Mari ^a  

^a Department of Medical Microbiology ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; HELICOBACTER PYLORI VACCINE; IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; O ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELL LYSATE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNIZATION; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFECTION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; MALE; MICE; MICE, INBRED C57BL; VACCINES, INACTIVATED;

EID: 0036841031     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.11.6383-6388.2002     Document Type: Article

References (32)

1. Achtman, M., G. Morelli, and S. Schwuchow. 1978. Cell-cell interactions in conjugating Escherichia coli: role of F pili and fate of mating aggregates. J. Bacteriol. 135:1053-1061.
2. Aebischer, T., S. Laforsch, R. Hurwitz, F. Brombacher, and T. F. Meyer. 2001. Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice. Infect. Immun 69:556-558.
3. Blaser, M. J. 1990. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J. Infect. Dis. 161:626-633.
4. Crespi, M., and F. Citarda. 1998. Helicobacter pylori and gastric cancer: what is the real risk? Gastroenterologist 6:16-20.
5. Dixon, M. F., R. M. Genta, J. H. Yardley, and P. Correa. 1996. Classification and grading of gastritis. The updated Sydney System International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20:1161-1181.
6. Ermak, T. H., R. Ding, B. Ekstein, J. Hill, G. A. Myers, C. K. Lee, J. Pappo, H. K. Kleanthous, and T. P. Monath. 1997. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology 113:1118-1128.
7. Ferrero, R. L., J. M. Thiberge, I. Kansau, N. Wuscher, M. Huerre, and A. Labigne. 1995. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc. Natl. Acad. Sci. USA 92:6499-6503.
8. Ghiara, P., M. Rossi, M. Marchetti, A. Di Tommaso, C. Vindigni, F. Ciampolini, A. Covacci, J. L. Telford, M. T. De Magistris, M. Pizza, R. Rappuoli, and G. Del Giudice. 1997. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect. Immun. 65:4996-5002.
9. Gurel, S., F. Besisk, K. Demir, Z. Mungan, S. Kaymakoglu, G. Boztas, Y. Cakaloglu, O. Yeginsu, and A. Okten. 1999. After the eradication of Helicobacter pylori infection, relapse is a serious problem in Turkey. J. Clin. Gastroenterol. 28:241-244.
10. Holmgren, J., A. M. Svennerholm, M. Jertborn, J. Clemens, D. A. Sack, R. Salenstedt, and H. Wigzell. 1992. An oral B subunit: whole cell vaccine against cholera. Vaccine 10:911-914.
11. Ikewaki, J., A. Nishizono, T. Goto, T. Fujioka, and K. Mifune. 2000. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection. Microbiol. Immunol. 44:29-39.
12. Johansson, E. L., C. Rask, M. Fredriksson, K. Eriksson, C. Czerkinsky, and J. Holmgren. 1998. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect. Immun. 66:514-520.
13. Keenan, J., J. Oliaro, N. Domigan, H. Potter, G. Aitken, R. Allardyce, and J. Roake. 2000. Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect. Immun. 68:3337-3343.
14. Kotloff, K. L., M. B. Sztein, S. S. Wasserman, G. A. Losonsky, S. C. DiLorenzo, and R. I. Walker. 2001. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect. Immun. 69:3581-3590.
15. Lee, A., J. O'Rourke, M. C. De Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112:1386-1397.
16. Lindholm, C., J. Osek, and A. M. Svennerholm. 1997. Quantification of conserved antigens in Helicobacter pylori during different culture conditions. Infect. Immun. 65:5376-5380.
17. Lindholm, C., M. Quiding-Jarbrink, H. Lonroth, A. Hamlet, and A. M. Svennerholm. 1998. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 66:5964-5971.
18. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1315.
19. Mattsson, A., H. Lonroth, M. Quiding-Jarbrink, and A. M. Svennerholm. 1998. Induction of B cell responses in the stomach of Helicobacter pyloriinfected subjects after oral cholera vaccination. J. Clin. Investig. 102:51-56.
20. Mohammadi, M., S. Czinn, R. Redline, and J. Nedrud. 1996. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156:4729-4738.
21. Pappo, J., D. Torrey, L. Castriotta, A. Savinainen, Z. Kabok, and A. Ibraghimov. 1999. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun. 67:337-341.
22. Patchett, S., S. Beattie, E. Leen, C. Keane, and C. O'Morain. 1992. Helicobacter pylori and duodenal ulcer recurrence. Am. J. Gastroenterol. 87:24-27.
23. Qadri, F., C. Wenneras, F. Ahmed, M. Asaduzzaman, D. Saha, M. J. Albert, R. B. Sack, and A. Svennerholm. 2000. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children. Vaccine 18:2704-2712.
24. Quiding-Jarbrink, M., H. Lonroth, I. Ahlstedt, J. Holmgren, and A. M. Svennerholm. 2001. Human gastric B cell responses can be induced by intestinal immunisation. Gut 49:512-518.
25. Radcliff, F. J., and R. L. Ferrero. 2001. Effect of low-dose antigen exposure on development of immunity to Helicobacter pylori infection in mice. Infect. Immun. 69:5186-5188.
26. Radcliff, F. J., S. L. Hazell, T. Kolesnikow, C. Doidge, and A. Lee. 1997. Catalase, a novel antigen for Helicobacter pylori vaccination. Infect. Immun. 65:4668-4674.
27. Raghavan, S., A. Svennerholm, and J. Holmgren. 2002. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis. Infect. Immun. 70:4621-4627.
28. Satin, B., G. Del Giudice, V. Della Bianca, S. Dusi, C. Laudanna, F. Tonello, D. Kelleher, R. Rappuoli, C. Montecucco, and F. Rossi. 2000. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 191:1467-1476.
29. Simoons-Smit, I. M., B. J. Appelmelk, T. Verboom, R. Negrini, J. L. Penner, G. O. Aspinall, A. P. Moran, S. F. Fei, B. S. Shi, W. Rudnica, A. Savio, and J. de Graaff. 1996. Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide. J. Clin. Microbiol. 34:2196-2200.
30. Sutton, P., J. Wilson, and A. Lee. 2000. Further development of the Helicobacter pylori mouse vaccination model. Vaccine 18:2677-2685.
31. Tinnert, A., A. Mattsson, I. Bolin, J. Dalenback, A. Hamlet, and A. M. Svennerholm. 1997. Local and systemic immune responses in humans against Helicobacter pylori antigens from homologous and heterologous strains. Microb. Pathog. 23:285-296.
32. Veenendaal, R. A., A. S. Pena, J. L. Meijer, H. P. Endtz, M. M. van der Est, W. van Duijn, F. Eulderink, J. Kreuning, and C. B. Lamers. 1991. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 32:1291-1294.